Antonio Alcala Malave
Antonio Alcalá Malavé (Malaga, Spain, 1964) is neurocientist, expert on brain biochemistry, neurobiology and DNA. He is specialized in ophthalmology and neurology of vision. He has been awarded 4 national prizes in medicine by the Institute of Spain through the Royal Academy of Medicine (Best Cardiology Research Award in 2000 and Best Chronopathology Research Award in 2008) and through The Royal Academy of Medicine and Surgery of Cadiz (Best Ophthalmology Research Award in 2002 and Best Alzheimer's disease Rearch Work Award in 2005).
He is Corresponding Member at The Royal Academy of Medicine and Surgery of Cadiz (Western Andalusia) and Merit Member at Malaga Academy of Science (http://www.academiamalaguenadeciencias.com/index.html).
He is a pioneer on researching neuroscience applied to vision and emotions. He is a former professor of advanced studies in Clinical Chemistry and Molecular Pathology at the University of Malaga. He is professor of Regressive Therapy and Clinical Hypnosis and Neuroscience at the International Association of Clinical and Experimental Hypnosis. His main line of research is based on the connection between cardiovascular diseases and dementias with vision. In 2001 and 2002 he publishes two works in which he proves that the Brodman areas 17, 18 and 19 do not only work for producing the physical-chemical phenomenon of vision, if not they can inform about the cardiovascular risk. Specifically, both researches reported that patients with high levels of cholesterol lose color vision and that a drug used for treating myocardial infarction (pravastatin) made vary from black to white to the full color spectrum. Between 2007 and 2010 he reports that the cardiovascular risk related to hypercholesterolemia produces a visual failure when capturing the light which is measurable using computerized perimetry, test that, up to then, was used for the glaucoma diagnosis. He also reports connections between dementias and brain areas for vision. Nowadays he works searching for nexuses between human genome and vision. He also follows a line of research on experimental hypnosis searching for connections between emotions, thoughts and their influence on human genome.
History[edit | edit source]
He graduated in Medicine and Surgery with outstanding grades in 1989 at the University of Malaga. He studied his doctorate in Ophthalmology at the Instituto Castroviejo in the Complutense University of Madrid and at the Instituto de Oftalmobiologia Aplicada at the University of Valladolid between 1993-1995. Additionally, in 1995 he finished his doctorate studies in Neuroscience. In 2010 he received his PhD in Clinical Chemistry and Molecular Pathology at the University of Malaga.
Works[edit | edit source]
Here are his main publications:
- Alcalá Malavé A, Morell M, Rius F. El análisis computerizado cromático es un indicador precoz de riesgo cardiovascular asociado a hipercolesterolemia. (Computerized chromatic analysis is an early indicator of cardiovascular risk associated with hypercholesterolemia) Rev esp cardiol 2001; 54: (1417-1425). Scientific impact: 2.227
- Alcalá Malavé A, Morell M, Rius F. Comparative study of the impact of diet versus pravastatin on color vision in Brodmann area 19 detected by computerized chromatic analysis ( The CARDIOCOLOUR Study) Rev esp cardiol 2002; 55: 1243 – 1250. Scientific impact: 2.227
- Alcalá A, Jansen S, Farkouh M, Morell M. Hypercholesterolemia produces visual field alterations detectable with computerized perimetry. Atherosclerosis 2007; 195:167-71. Scientific impact: 4.287
- Alcalá A, Jansen S, Farkouh M , Téllez T, Gómez-huelgas R, Pérez O, Egido J, Statins improve visual field alterations related to hypercholesterolemia. Atherosclerosis 2010; 209:510-514. Scientific impact: 4.601
Scientific impact[edit | edit source]
- Comparative study of the impact of diet versus pravastatin on color vision in Brodmann area 19 detected by computerized chromatic analysis (The CARDIOCOLOUR Study) is ranked 47th in the Top 100 Best Articles in Neuroscience.
- Statins improve visual field alterations related to hypercholesterolemia is ranked 4th as scientific discovery about statins http://biomedupdater.com/ and 13th in the World's Top 100 Best Articles in Ophthalmology associated with cardiology. (http://www.cpcardiology.com/article/PIIS0021915007000548/related). It is also ranked 44th in the world by relevance of the biomedical discovery on cholesterol and other lipids in blood http://www.recentmedicalfindings.com/g0n3/cholesterol-ldl-5.html
- Hypercholesterolemia produces visual field alterations detectable with computerized perimetry is ranked 9th as scientific discovery about statins http://wipimd.com&kwr=e8fhef7a5482ef16390ea733a04cf1685a15f2875a87fa06b4b56f343b139135cdf91477dc98351fcd616b371ec58e3ac8f52b7ff0d903141f535f2877ad50c211a524a87a5c00fbb603b644f729fa9345055acd4073ee2c7ae08826aa568d3f05b9c775ba12358a68e6f810a2g45c&kwr=&ck=&cxts=10&fntszff=100&hghlght=maroon&srtrdr=relevance&annttn=none&pdthm=2010&hqryhstry=5062b3f288e4d101&pgwdth=100&mld=KED40419T07727521158&wft=wims&b4s=225061634&rcdd=143689589806252294076455297c5da9ca50c2d20f5cc79f78a0&ndpct=6e096672b77886eb5247cbfa90b0a7ac013de923334e0ee5a774eb8d1b7132ad. It is also ranked 20th in the World's Top 100 Best Articles in Cardiovascular Medicine
These last two, are ranked 8th and 9th in the top best articles about retina and microcirculation published in "Atherosclerosis" magazine http://journals.elsevierhealth.com/periodicals/ath/search/quick?restrictName.ath=ath&search_area=journal&search_text1=Retinal+microcirculation.
As of today they are by relevance the best positioned Spanish works of scientific medicine in ophthalmology.
Honors[edit | edit source]
- 1996 Doctor of Medicine and Surgery cum laude (PhD in Neurosciences)
- 1997 Diploma in Chibret National Award of Ophthalmology for the scientific qualities of his doctoral dissertation
- 2000 Royal Academy of Medicine Award for the Best Cardiology Research
- 2002 Royal Academy of Medicine and Surgery of Cadiz Award (Western Andalusia area) for the Best Ophthalmology Research
- 2002 Corresponding Member at The Royal Academy of Medicine and Surgery of Cadiz (Western Andalusia area). Qv Reales Academias
- 2005 Royal Academy of Medicine and Surgery of Cadiz Award for the Best Alzheimer's Disease Research Work
- 2007 Knight Commander of Justice at the Order of Saint Lazarus of Jerusalem
- 2008 Royal Academy of Medicine Award for the Best Chronopathology Research
- 2009 Medal of Honor of the Grand Priory in Spain of the Order of Saint Lazarus
- 2009 Scientific Committee Member of the College of Physicians http://www.commalaga.com/
- 2010 Knight at the Order of Saint Michael of the Wing (Portugal)
- 2010 Doctor of Clinical Biochemistry and Molecular Pathology cum laude
- 2010 Merit Academician of the Malaga Academy of Sciences. Qv Reales Academias
- 2011 Medal of Honor of the Grand Priory in Spain of the Order of Saint Lazarus of Jerusalem, Malta, Bethlehem and Nazareth
- 2015 Professor in Hypnosis and Neuroscience at the International Association of Clinical and Experimental Hypnosis
- 2015 Professor in Hypnosis and Neuroscience at the Universitas Privada Hipnosis Clínica ( U.P.H.C)
Books[edit | edit source]
- 2015 "Genética de la emoción: el origen de la enfermedad" (Genetics of the emotion: the origin of the disease) Ediciones B http://www.edicionesb.com/catalogo/libro/genetica-de-emocion-origen-de-enfermedad_3771.html
- 2016 " Hipnosis clínica y psicologia" (Clinical hypnosis and psychology) AIHCE http://aihce.net/hipnosis-clnica-y-psicologia/ as coauthor
References[edit | edit source]
Antonio Alcala Malave[edit | edit source]
This article "Antonio Alcala Malave" is from Wikipedia. The list of its authors can be seen in its historical and/or its subpage Antonio Alcala Malave/edithistory. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.